Source: https://www.law.cornell.edu/cfr/text/21/60.1
Timestamp: 2016-02-06 08:24:48
Document Index: 713584999

Matched Legal Cases: ['art 60', '§ 60', '§ 348', '§ 355', '§ 360', '§ 360', '§ 371', '§ 379']

21 CFR 60.1 - Scope. | US Law | LII / Legal Information Institute
CFR › Title 21 › Chapter I › Subchapter A › Part 60 › Subpart A › Section 60.1 21 CFR 60.1 - Scope.
This part sets forth procedures and requirements for the Food and Drug Administration's review of applications for the extension of the term of certain patents under 35 U.S.C. 156. Patent term restoration is available for certain patents related to drug products (as defined in 35 U.S.C. 156(f)(2)), and to medical devices, food additives, or color additives subject to regulation under the Federal Food, Drug, and Cosmetic Act or the Public Health Service Act. Food and Drug Administration actions in this area include:
Assisting the United States Patent and Trademark Office in determining eligibility for patent term restoration;
If petitioned, reviewing and ruling on due diligence challenges to the Food and Drug Administration's regulatory review period determinations; and
Conducting hearings to review initial Food and Drug Administration findings on due diligence challenges.
References in this part to the Code of Federal Regulations are to chapter I of title 21, unless otherwise noted.
§ 60.1 Scope.
(a) This part sets forth procedures and requirements for the Food and Drug Administration's review of applications for the extension of the term of certain patents under 35 U.S.C. 156. Patent term restoration is available for certain patents related to drug products (as defined in 35 U.S.C. 156(f)(2)), and to medical devices, food additives, or color additives subject to regulation under the Federal Food, Drug, and Cosmetic Act or the Public Health Service Act. Food and Drug Administration actions in this area include:
(1) Assisting the United States Patent and Trademark Office in determining eligibility for patent term restoration;
(2) Determining the length of a product's regulatory review period;
(3) If petitioned, reviewing and ruling on due diligence challenges to the Food and Drug Administration's regulatory review period determinations; and
(4) Conducting hearings to review initial Food and Drug Administration findings on due diligence challenges.
(b) References in this part to the Code of Federal Regulations are to chapter I of title 21, unless otherwise noted.
This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.This list is taken from the Parallel Table of Authorities and Rules provided by GPO [Government Printing Office].It is not guaranteed to be accurate or up-to-date, though we do refresh the database weekly. More limitations on accuracy are described at the GPO site.United States CodeU.S. Code: Title 21 - FOOD AND DRUGS§ 348 - Food additives§ 355 - New drugs§ 360e - Premarket approval§ 360j - General provisions respecting control of devices intended for human use§ 371 - Regulations and hearings§ 379e - Listing and certification of color additives for foods, drugs, devices, and cosmetics